Evidence map›Paper›PMID 28821580›Full record

ArticleRNA (New York, N.Y.)2017

Cap-independent translation ensures mTOR expression and function upon protein synthesis inhibition.

Ana Marques-Ramos, Marco M Candeias, Juliane Menezes, Rafaela Lacerda, Margaret Willcocks, Alexandre Teixeira, Nicolas Locker, Luísa Romão

Abstract read
In one paragraph

Article in RNA (New York, N.Y.), 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Review
  10. Review
  11. Review
  12. Article
  13. Article
  14. Review
  15. Article
  16. Review
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Ana Marques-RamosDepartamento de Genética Humana, Instituto Nacional de Saúde Doutor Ricardo Jorge, 1649-016 Lisboa, Portugal.
Marco M CandeiasDepartamento de Genética Humana, Instituto Nacional de Saúde Doutor Ricardo Jorge, 1649-016 Lisboa, Portugal.
Juliane MenezesDepartamento de Genética Humana, Instituto Nacional de Saúde Doutor Ricardo Jorge, 1649-016 Lisboa, Portugal.
Rafaela LacerdaDepartamento de Genética Humana, Instituto Nacional de Saúde Doutor Ricardo Jorge, 1649-016 Lisboa, Portugal.
Margaret WillcocksMicrobial and Cellular Sciences Department, Faculty of Health and Medical Sciences, University of Surrey, Guildford GU2 7TE, United Kingdom.
Alexandre TeixeiraDepartamento de Genética Humana, Instituto Nacional de Saúde Doutor Ricardo Jorge, 1649-016 Lisboa, Portugal.
Nicolas LockerMicrobial and Cellular Sciences Department, Faculty of Health and Medical Sciences, University of Surrey, Guildford GU2 7TE, United Kingdom.
Luísa RomãoDepartamento de Genética Humana, Instituto Nacional de Saúde Doutor Ricardo Jorge, 1649-016 Lisboa, Portugal luisa.romao@insa.min-saude.pt.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The mechanistic/mammalian target of rapamycin (mTOR) is a conserved serine/threonine kinase that integrates cellular signals from the nutrient and energy status to act, namely, on the protein synthesis machinery. While major advances have emerged regarding the regulators and effects of the mTOR signaling pathway, little is known about the regulation of

Indexed as

5' Untranslated RegionsAnimalsCell HypoxiaCell LineEvolution, MolecularGene Expression RegulationHCT116 CellsHEK293 CellsHeLa CellsHumansHydrazonesLuciferases, FireflyProtein BiosynthesisProtein Synthesis InhibitorsRNA CapsRNA Folding4EGI-1 compound5' Untranslated RegionsHydrazonesLuciferases, FireflyMTOR protein, humanProtein Synthesis InhibitorsRNA CapsRNA, MessengerThiazolesTOR Serine-Threonine Kinasescap-independent translationCITEIRESmechanistic target of rapamycin (mTOR)translational controltranslation initiation

Identifiers

PMID28821580
PMCPMC5648038

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.